The Regulatory Review

SpaceX is reportedly targeting an unusually rapid launch cadence for its Starship program, with three flights within roughly five weeks. The pace would mark a significant step up from previous testing, reflecting the company's push to iterate quickly on the vehicle and demonstrate reusability. Space enthusiasts are debating whether the schedule is realistic given past delays and regulatory review requirements.

New research has identified 485 chemicals used in US pesticide products that are linked to breast cancer. The findings, reported by The Guardian, are raising concerns about consumer and worker exposure to common agricultural chemicals and prompting calls for tighter regulation and further safety review of pesticide ingredients.

Paramount and several state regulators are pushing back against demands for a more extensive review of its pending merger deal. Both the company and the states involved have rejected calls to widen the examination of the transaction, signalling they want the approval process to proceed without further delays or added scrutiny.

South Korean authorities are re-examining the country's ban on crypto market-making activity amid a rapid rise in stablecoin trading and interest. Regulators are weighing whether the prohibition still fits a market increasingly shaped by stablecoins, and the review has drawn attention from investors and industry players watching whether Seoul will loosen rules for domestic crypto trading.

The Regulatory Review argues that meaningful transparency from AI labs is essential for any future US-China agreement on artificial intelligence. Without verifiable disclosure of how advanced models are developed and deployed, Washington and Beijing would struggle to build the mutual trust needed for limits on frontier AI. The piece frames openness by companies as a precondition for international AI governance.

Researchers publishing in Communications Biology report that deletions and regulatory disruption of the Y chromosome recur across cancers, suggesting loss of this chromosome may play a functional role in tumour development rather than being a harmless byproduct. The findings add to growing interest in how sex chromosome instability shapes cancer risk and progression in men.

The US Food and Drug Administration has released draft guidance covering cardiovascular surgical robots, outlining its current thinking for developers and manufacturers of these devices. The document, reported by Cardiovascular Business, is expected to shape how robotic systems for heart procedures are designed, tested and cleared. Stakeholders in medical robotics will likely review the draft and submit comments before final guidance is issued.

The US Nuclear Regulatory Commission has completed its environmental review of the planned restart of the Crane Clean Energy Center in Pennsylvania, a key step toward restarting the former Three Mile Island Unit 1 reactor. The review clears a major regulatory hurdle for the project, which Microsoft has agreed to support through a power purchase deal to supply its data centres with nuclear energy.

Federal regulators have finalized the environmental impact study for the proposed expansion of the Sabine Pass liquefied natural gas export facility on the Louisiana-Texas coast. The completion of the environmental review is a key step toward a final decision on the expansion, which would boost US LNG export capacity. The project is significant for global energy markets amid ongoing demand for American natural gas.

The FDA has released new guidance establishing a common playbook for companies developing surgical robots. The framework is expected to give robotic surgery manufacturers a clearer, more consistent path through regulatory review. Industry watchers say it could lower barriers for new entrants and speed approval of next-generation surgical robotics systems across the market.

A National Review commentary argues that Donald Trump's profiteering through Truth Social can only be addressed by Congress, which holds constitutional tools to check a sitting president's financial entanglements. The piece frames congressional action as the sole viable avenue, since conventional enforcement mechanisms are constrained by Trump's control over the Justice Department and regulatory agencies.

The FDA's single institutional review board rule for multisite clinical trials will take effect in December 2026. Under the policy, one IRB will review studies conducted at multiple US sites, replacing the current patchwork of separate local reviews. Industry observers are weighing how the change will affect trial timelines, oversight responsibilities and costs for sponsors and research institutions.

The Downtown Dova development is set to go before the Rancho Cordova planning commission for review. The project would be a significant addition to the Sacramento-area suburb's push to build out a more urban downtown core, and local business and civic observers are watching how commissioners respond to the proposal at the upcoming hearing.